Resultados de procura - S. REVEL‐VILK

Limitar resultados
  1. 1
    Fertility preservation in young cancer patients

    Fertility preservation in young cancer patients por Revel, Ariel, Revel-Vilk, Shoshana

    Publicado 2010
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  2. 2
    Patient blood management programs: how to spread the word?

    Patient blood management programs: how to spread the word? por Revel-Vilk, Shoshana, Naamad, Mira

    Publicado 2018
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  3. 3
    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review por Shoshana Revel‐Vilk, Maria Fuller, Ari Zimran

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Impact of Gaucher disease on COVID‐19

    Impact of Gaucher disease on COVID‐19 por Zimran, Ari, Szer, Jeff, Revel‐Vilk, Shoshana

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  5. 5
    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review por Revel-Vilk, Shoshana, Fuller, Maria, Zimran, Ari

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  6. 6
    A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact

    A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact por Zimran, Ari, Ruchlemer, Rosa, Revel-Vilk, Shoshana

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  7. 7
    How we manage Gaucher Disease in the era of choices

    How we manage Gaucher Disease in the era of choices por Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease

    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease por Shoshana Revel‐Vilk, Anthony K.C. Chan, Mary Bauman, Patricia Massicotte

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Official communication of the SSC: Recommendations for future research in catheter‐related arterial thrombosis in children

    Official communication of the SSC: Recommendations for future research in catheter‐related arterial thrombosis in children por Albisetti, Manuela, Rizzi, Mattia, Bonduel, Mariana, Revel‐Vilk, Shoshana, Goldenberg, Neil

    Publicado 2019
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  10. 10
    The clinical course of bronchiolitis associated with acute otitis media

    The clinical course of bronchiolitis associated with acute otitis media por Shazberg, G., Revel-Vilk, S., Shoseyov, D., Ben-Ami, A., Klar, A., Hurvitz, H.

    Publicado 2000
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  11. 11
    Second bone marrow transplantation for patients with thalassemia: risks and benefits

    Second bone marrow transplantation for patients with thalassemia: risks and benefits por Stepensky, Polina, Or, Reuven, Shapira, Michael Y, Revel-Vilk, Shoshana, Stein, Jerry, Resnick, Igor B.

    Publicado 2009
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  12. 12
    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replaceme... por Noa Hurvitz, Tama Dinur, Shoshana Revel‐Vilk, Samuel Agus, Marc Berg, Ari Zimran, Yaron Ilan

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Anemia in Children with Down Syndrome

    Anemia in Children with Down Syndrome por Tenenbaum, Ariel, Malkiel, Sarah, Wexler, Isaiah D., Levy-Khademi, Floris, Revel-Vilk, Shoshana, Stepensky, Polina

    Publicado 2011
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  14. 14
    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene

    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene por Eyal Shteyer, Ann Saada, Avraham Shaag, Fida’ Al‐Hijawi, Rojette Kidess, Shoshanah Revel-Vilk, Orly Elpeleg

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: a systematic review

    Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: a systematic review por Sharathkumar, Anjali A., Biss, Tina, Kulkarni, Ketan, Ahuja, Sanjay, Regan, Matt, Male, Christoph, Revel-Vilk, Shoshana

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  16. 16
    Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease

    Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease por Dinur, Tama, Istaiti, Majdolen, Frydman, Dafna, Becker-Cohen, Michal, Szer, Jeff, Zimran, Ari, Revel-Vilk, Shoshana

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  17. 17
    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene

    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene por Shteyer, Eyal, Saada, Ann, Shaag, Avraham, Al-Hijawi, Fida' Aziz, Kidess, Rojette, Revel-Vilk, Shoshanah, Elpeleg, Orly

    Publicado 2009
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  18. 18
    Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations

    Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Fo... por Dinur, Tama, Grittner, Ulrike, Revel-Vilk, Shoshana, Becker-Cohen, Michal, Istaiti, Majdolen, Cozma, Claudia, Rolfs, Arndt, Zimran, Ari

    Publicado 2021
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  19. 19
    Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease

    Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease por Weill, Yishay, Zimran, Ari, Zadok, David, Wasser, Lauren M., Revel-Vilk, Shoshana, Hanhart, Joel, Dinur, Tama, Arkadir, David, Becker-Cohen, Michal

    Publicado 2020
    Ligazón do recurso Ligazón do recurso Ligazón do recurso
    Text
    Engadir a favoritos
    Gardado en:
  20. 20
    Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations

    Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations por Neil A. Goldenberg, Leonardo R. Brandão, Janna M. Journeycake, Susan R. Kahn, Paul Monagle, S. REVEL‐VILK, Anjali Sharathkumar, Anthony K.C. Chan

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: